Home › Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation From FDA, Baron & Budd Reports
 

Keywords :   


Mesothelioma Immunotherapy Vaccine Receives Orphan Drug Designation From FDA, Baron & Budd Reports

2015-04-29 04:58:10| drugdiscoveryonline Home Page

The mesothelioma law firm of Baron & Budd reports the U.S

Tags: reports drug receives designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05BeautyHealth: Q1 2024 Financials
10.05Research Institute for Fragrance Materials to Promote Online Database on May 22
10.05Hairstory Promotes Dina Rosenbloom To Chief Executive Officer
10.05Net Sales Decrease 5% for The Clorox Company in Q3 2024
10.05Sunak says it'll take time for people to feel better
10.05Alabama second state to ban lab-grown meat
10.05Alabama second state to ban lab-grown meat
10.05Senators request more aggressive approach on HPAI countermeasures
More »